The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > BUSINESS
BUSINESS
- Novartis’s 11-Year Research Grants to 5 Universities Total 1.1 Billion Yen
August 13, 2013
- JPWA Operating Profit Margin at 0.63%, First Gross Profit Margin Rise Since FY2007
August 13, 2013
- MSD Paid 20.8 Billion Yen to Doctors, Medical Institutions in FY2012
August 13, 2013
- Payments to Healthcare Professionals by 10 Drug Makers Top 150 Billion Yen
August 13, 2013
- Otsuka Holdings’ Pharmaceutical Sales Rise 14.8%, Global Sales for Abilify Up 21.9% in April-June Period
August 12, 2013
- Novartis Corrects Third-Party Investigation Report on Diovan Studies
August 12, 2013
- DSP to Set Up Regenerative & Cellular Medicine Office for Integrated Management of All Related Functions
August 12, 2013
- AZ’s Exenatide Promotion to Break Free from Weight-Loss Image of GLP-1 Receptor Agonists
August 9, 2013
- Ethical Drug Sales Down 0.1% in June: Crecon Report
August 9, 2013
- Seikagaku Obtains Favorable Results from PIII Study of Condoliase for Lumbar Disc Herniation, Plans to File NDA in Japan During FY2013
August 9, 2013
- Meiji Seika Pharma Changes New Drug Plan in the CNS Field; Filing and Launch of Asenapine to Take Priority
August 9, 2013
- Sawai Lifts Limit Restrictions on Atelec Generic Supplies
August 8, 2013
- DSP Aims for Better Communications with Wholesalers, Regulators with Tokyo-Osaka Two Head Office System
August 8, 2013
- Top 4 Wholesalers Report Average Price Agreement Rate of 63.4% at End of June, Down 7.5 Points from 2 Years Prior
August 8, 2013
- Takeda to Merge Bio Development Center following Acquisition of Its Operations
August 7, 2013
- Eli Lilly Paid 16.3 Billion Yen in 2012 to Doctors, Medical Institutions
August 7, 2013
- Janssen, Mochida to Comarket Pain Treatment Tramcet Combination Tablets from October
August 6, 2013
- Toyama Chemical Starts Commercial Production at Newly-Established Plant for Injectables
August 6, 2013
- Eisai Sales Up 5.0%, Helped by Growth of New Products
August 5, 2013
- Sales of Eisai’s Obesity Treatment Belviq Exceeds US$10 Million Three Weeks after Launch
August 5, 2013
ページ
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…